Tag: FDA

FDA revises EUAs for N95 decontamination systems

Editor's Note The Food and Drug Administration on January 21 reissued emergency use authorizations (EUAs) for 10 systems used to decontaminate N95 respirators used by healthcare personnel . The 10 systems are: Michigan State University Decontamination System Technical Safety Services VHP Decontamination System Stryker Sustainability Solutions VHP Decontamination System STERIS…

Read More

By: Judy Mathias
January 26, 2021
Share

Willingness of US adults to get the COVID-19 vaccine

Editor's Note This study led by researchers from the Virginia Commonwealth University, Richmond, finds that COVID-19 vaccine-related messaging should address concerns about the vaccine and its development and reinforce its benefits to increase the willingness of US adults to get the COVID-19 vaccine and to get the vaccine under an…

Read More

By: Judy Mathias
January 20, 2021
Share

Parsing COVID-19 transmission routes informs levels of protection needed

Information about COVID-19 transmission and treatment has evolved between the time this infectious disease first emerged and now. As evidence-based knowledge grows and protocols change, and as populations are vaccinated to develop herd immunity, there is increasing optimism about the ability to combat the virus. Meanwhile, it is important to…

Read More

By: Judith M. Mathias, MA, RN
January 19, 2021
Share

Supply chain strategies shift to meet pandemic-induced demands

Resiliency, a term that has cropped up repeatedly during the COVID-19 pandemic, is often considered a key defense against burnout. But it is also important in the context of the healthcare supply chain, says Ed Hisscock, senior vice president of supply chain management at Trinity Health, a 22-state healthcare system…

Read More

By: Elizabeth Wood
January 19, 2021
Share

Editorial

The rollout of COVID-19 vaccines starting in December 2020 was the one bright spot in an otherwise tragic year with a rapidly rising death toll currently over 385,000. Distribution of the 20 million doses promised by year end was thwarted by problems such as lack of coordination and lack of…

Read More

By: Elizabeth Wood
January 19, 2021
Share

Expanding reprocessing programs can yield cost savings

The financial impact of COVID-19 on healthcare providers has been considerable. With experts predicting that half of all US hospitals would be operating in the red by the end of 2020, healthcare leaders have had to seek multiple ways to cut costs. The expansion of single-use medical device (SUD) reprocessing…

Read More

By: OR Manager
January 19, 2021
Share

CDC: Updated interim recommendation for allocation of COVID-19 vaccine

Editor’s Note On December 20, 2020, the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) updated its interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be offered to persons aged 75 years or more and non-healthcare frontline essential workers. In Phase 1c, the vaccine should be…

Read More

By: Judy Mathias
January 5, 2021
Share

Pfizer/BioNTech vaccine reaches 141 of 145 first-day locations

Editor's Note The first batch of the Pfizer/BioNTech's newly authorized COVID-19 vaccine for emergency use reached 141 of 145 targeted locations on the first day of its national rollout, a Department of Health and Human Services spokeswoman told Reuters. Four island territories—American Samoa, Guam, North Mariana Islands, and the US…

Read More

By: Judy Mathias
December 15, 2020
Share

HHS purchases 100 million additional doses of Moderna’s COVID-19 vaccine

Editor's Note The Department of Health and Human Services (HHS) announced on December 11 that it would purchase 100 million additional doses of Moderna’s COVID-19 vaccine. The vaccine, which was developed by Moderna with scientists from the National Institute of Allergy and Infectious Diseases (NIAID), is scheduled for a December…

Read More

By: Judy Mathias
December 15, 2020
Share

ICU nurse receives first Pfizer/BioNTech COVID-19 vaccine in US

Editor's Note After the Food and Drug Administration issued an Emergency Use Authorization for Pfizer/BioNTech’s COVID-19 vaccine on December 11, the company began shipping 2.9 million doses to 636 sites throughout the US. (https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19). On December 14, the first dose of the vaccine was administered at 9:23 am to an…

Read More

By: Judy Mathias
December 14, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat